{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:47:30Z","timestamp":1724978850445},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.hfc.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:49:24Z","timestamp":1724964564000},"page":"407-417","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy"],"prefix":"10.1016","volume":"20","author":[{"given":"Mohsin","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2024.06.007_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib2","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.recesp.2021.11.027","volume":"75","author":"McDonagh","year":"2022","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib4","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.06.007_bib5","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccep.2017.07.003","article-title":"Sudden cardiac death: interface between pathophysiology and epidemiology","volume":"9","author":"Myerburg","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hfc.2024.06.007_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib9","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pcad.2019.05.002","article-title":"Sudden cardiac death in nonischemic cardiomyopathy","volume":"62","author":"Kadakia","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hfc.2024.06.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacep.2021.06.020","article-title":"Arrhythmic and mortality outcomes among ischemic versus nonischemic cardiomyopathy patients receiving primary ICD therapy","volume":"8","author":"Narins","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2024.06.007_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.06.007_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.121.056072","article-title":"Long-term follow-up of Danish (the Danish study to assess the efficacy of ICDs in patients with nonischemic systolic heart failure on mortality)","volume":"145","author":"Yafasova","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jamacardio.2017.0266","article-title":"Sudden cardiac arrest risk assessment: population science and the individual risk mandate","volume":"2","author":"Myerburg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/europace\/eux089","article-title":"Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-Danish trial era: results of the European Heart Rhythm Association survey","volume":"19","author":"Haugaa","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hfc.2024.06.007_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M17-0120","article-title":"Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"167","author":"Kolodziejczak","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib23","article-title":"Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: an updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology","author":"Theuns","year":"2022","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hfc.2024.06.007_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jchf.2020.06.015","article-title":"Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: a PARADIGM-HF analysis","volume":"8","author":"Rohde","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib26","first-page":"CD013650","article-title":"Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis","volume":"10","author":"Kanie","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hfc.2024.06.007_bib27","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2024.06.007_bib28","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","article-title":"Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy","volume":"63","author":"Goldberger","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/eurheartj\/ehy437","article-title":"Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar","volume":"40","author":"Gutman","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.06.007_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11886-019-1236-3","article-title":"Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy","volume":"21","author":"Akhtar","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2024.06.007_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4330\/wjc.v14.i3.139","article-title":"Arrhythmic risk stratification in ischemic, nonischemic and hypertrophic cardiomyopathy: a two-step multifactorial, electrophysiology study inclusive approach","volume":"14","author":"Arsenos","year":"2022","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib32","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ijcard.2014.08.068","article-title":"Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function","volume":"176","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11886-020-01343-9","article-title":"Sudden cardiac death prediction in nonischemic dilated cardiomyopathy: a multiparametric and dynamic approach","volume":"22","author":"Hammersley","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2024.06.007_bib34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jchf.2019.03.019","article-title":"Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the Danish Trial","volume":"7","author":"Kristensen","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11897-018-0416-6","article-title":"Who benefits from a defibrillator-balancing the risk of sudden versus non-sudden death","volume":"15","author":"Beggs","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hfc.2024.06.007_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccep.2017.07.014","article-title":"Biomarkers to predict cardiovascular death","volume":"9","author":"Dhindsa","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hfc.2024.06.007_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.116.027134","article-title":"Personalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future","volume":"136","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib39","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium dnhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.120.047640","article-title":"Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias","volume":"143","author":"Muser","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib41","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","article-title":"Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death?","volume":"83","author":"van Berlo","year":"2005","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ehf2.13100","article-title":"Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry","volume":"8","author":"Asselbergs","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"van den Hoogenhof","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \"idiopathic\" left ventricular dysfunction","volume":"111","author":"Kuhl","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00059-012-3679-9","article-title":"Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy","volume":"37","author":"Maisch","year":"2012","journal-title":"Herz"},{"key":"10.1016\/j.hfc.2024.06.007_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/08916930802031546","article-title":"Anti-heart autoantibodies in familial dilated cardiomyopathy","volume":"41","author":"Caforio","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.hfc.2024.06.007_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","article-title":"Lethal immunoglobulins: autoantibodies and sudden cardiac death","volume":"18","author":"Ryabkova","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.hfc.2024.06.007_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/eurjhf\/hfq198","article-title":"Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy","volume":"13","author":"Xiao","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ehjqcco\/qcab044","article-title":"Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden","volume":"8","author":"Li","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.hfc.2024.06.007_bib53","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0735-1097(93)90546-D","article-title":"Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting","volume":"22","author":"Latif","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib54","doi-asserted-by":"crossref","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib56","doi-asserted-by":"crossref","first-page":"e010105","DOI":"10.1161\/CIRCIMAGING.119.010105","article-title":"Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR group","volume":"13","author":"Alba","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.06.007_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacep.2020.08.036","article-title":"Late-gadolinium enhancement interface area and electrophysiological simulations predict arrhythmic events in patients with nonischemic dilated cardiomyopathy","volume":"7","author":"Balaban","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/HPC.0000000000000171","article-title":"Myocardial fibrosis as a pathway of prediction of ventricular arrhythmias and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"18","author":"Centurion","year":"2019","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib59","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/CIRCULATIONAHA.120.048477","article-title":"Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy","volume":"143","author":"Klem","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib61","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy","volume":"77","author":"Di Marco","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib62","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib63","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","article-title":"Incremental prognostic value of myocardial fibrosis in patients with nonischemic cardiomyopathy without congestive heart failure","volume":"7","author":"Masci","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hfc.2024.06.007_bib64","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: the Seattle heart failure model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib66","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A\u00a0novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2024.06.007_bib67","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/CIRCULATIONAHA.111.025577","article-title":"Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men","volume":"125","author":"Kurl","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.06.007_bib68","doi-asserted-by":"crossref","first-page":"e006233","DOI":"10.1161\/CIRCEP.117.006233","article-title":"Mortality and sudden cardiac death risk stratification using the noninvasive combination of wide QRS duration and late gadolinium enhancement in idiopathic dilated cardiomyopathy","volume":"11","author":"Marume","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib69","doi-asserted-by":"crossref","first-page":"e12910","DOI":"10.1111\/anec.12910","article-title":"Fragmented QRS is associated with ventricular arrhythmias in heart failure patients: a systematic review and meta-analysis","volume":"27","author":"Engstrom","year":"2022","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib70","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.06.007_bib71","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib72","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.echo.2012.02.004","article-title":"Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography","volume":"25","author":"Haugaa","year":"2012","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2024.06.007_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2021.07.044","article-title":"Strain echocardiography improves prediction of arrhythmic events in ischemic and nonischemic dilated cardiomyopathy","volume":"342","author":"Melichova","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib74","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cjca.2019.11.009","article-title":"A\u00a0novel risk stratification score for sudden cardiac death prediction in middle-aged, nonischemic dilated cardiomyopathy patients: the ESTIMATED score","volume":"36","author":"Li","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hfc.2024.06.007_bib75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2021.07.002","article-title":"A\u00a0novel risk model for predicting potentially life-threatening arrhythmias in nonischemic dilated cardiomyopathy (DCM-SVA risk)","volume":"339","author":"Kayvanpour","year":"2021","journal-title":"Int J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T21:49:24Z","timestamp":1724968164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1551713624000527"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.06.007","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}